Therapanacea
AI software for radiotherapy planning and adaptive treatment workflows, built with clinicians for cancer centres and hospitals
Highlights
- New on EvolcAdded 2026-10-28
About Therapanacea
TheraPanacea develops AI software for radiation oncology. Its ART-Plan product automates structure and target delineation, treatment plan generation, and adaptive assessments and monitoring in radiotherapy workflows. The company says it is extending its technology to radioligand therapy and precision medicine.
Its customers are cancer centres, hospitals and oncology clinical teams, and healthcare systems. The company is built around collaboration with clinical teams across leading cancer centres.
TheraPanacea was founded in 2017 as a spin-off of Paris-Saclay University and is headquartered in Paris. It reports 75+ employees from 23 nationalities and says its work reaches 300 clinical sites across 5 continents. ART-Plan received CE and FDA approval for OAR delineation in 2019.
Product: ART-Plan, an AI software platform for radiotherapy segmentation, treatment planning and adaptive monitoring.
Public tenders won
1 tender won since 1 Jan 2024 from 1 public buyer in France. From EU award notices (TED) that name Therapanacea by its registry number.
- 25 Nov 2024 UNICANCER ACHATS · Fourniture, livraison, installation, mise en service, maintenance des solutions informatiques associées aux accélérateurs en radiothérapie pour les CLCC et les EA notice
Jobs at Therapanacea
Leadership
- Catherine Martineau-Huynh · Chief Strategic Alliances OfficerSource: company website
- Nikos Paragyios · CEO & FounderSource: company website
- Alexandre Favre · Chief Financial OfficerSource: company website
- Steve Andersen · Chief Revenue Officer & GM United StatesSource: company website
- Abhi Chakrabarti · Product & Marketing DirectorSource: company website
- Fabien Bellanger · Engineering DirectorSource: company website
- Marta Le Berthe · Culture & HR DirectorSource: company website
More health & medtech companies
Therapixel
Imaging AI software that helps radiologists detect breast cancer in mammography screeningNew on EvolcTheremia
AI models for optimising drug dosing and formulation in neurology and psychiatry, sold to biotech drug developersYoung companyNew on EvolcTherenva
AI-based endovascular planning and C-arm image fusion software for interventional cardiologists and vascular surgeonsNew on EvolcTheryq
Radiotherapy machines with linear accelerators, using FLASH technology, for cancer treatment centresNew on EvolcThinkin Tech
Wearable ultrasound guidance devices for aesthetic practitioners performing dermal filler injectionsYoung companyNew on EvolcTilak Healthcare
Remote monitoring app for ophthalmologists and patients with chronic retinal conditionsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- AWS
- Tailwind CSS
- nginx
